Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.


Strengths

● The company's profit outlook over the next few years is a strong asset.

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Considering the small differences between the analysts' various estimates, the group's business visibility is good.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 49.31 times its estimated earnings per share for the ongoing year.

● Based on current prices, the company has particularly high valuation levels.

● The company appears highly valued given the size of its balance sheet.

● The valuation of the company is particularly high given the cash flows generated by its activity.

● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.

● Most analysts recommend that the stock should be sold or reduced.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.